Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis

Journal of Infectious Diseases

Volumn 182, Issue 5, 2000, Pages 1536-1539

  Mastroianni, C M ^a   Mengoni, F ^a   Lichtner, M ^a   D'Agostino, C ^a   D'Ettorre, G ^a   Forcina, G ^a   Marzi, M ^a   Russo, G ^a   Massetti, A P ^a   Vullo, V ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

ADULT; AGED; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; LEUKOCYTE FUNCTION; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; CHEMOTAXIS, LEUKOCYTE; FEMALE; HIV PROTEASE INHIBITORS; HUMAN; IN VITRO; MALE; MIDDLE AGE; NEUTROPHILS; SUPPORT, NON-U.S. GOV'T;

EID: 0033787111     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315858     Document Type: Article

References (15)

1. Polymorphonuclear leukocyte function in HIV
2. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome
3. Reversal of accel erated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-GSF
4. Long-lasting recovery in CD4 T cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
5. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients
6. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
7. Caspase-mediated proteolysis and activation of protein kinase Cδ plays a central role in neutrophil activation
8. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors
9. + T cell apoptosis in HIV-infected patients
10. Clinical and immunological response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy
11. + T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection
12. + T cells and decreases their susceptibility to apoptosis in vitro and in vivo
13. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells
14. Decreased HIV-associated T cell apoptosis by HIV protease inhibitors
15. HIV protease inhihitors restore impaired T cell proliferative response in vivo and in vitro: A viral suppression-independent mechanism